T lymphocytes (CD3) may participate in the recurrence of cervical intraepithelial neoplasia grade III

Archives of Gynecology and Obstetrics

Volumn 278, Issue 6, 2008, Pages 525-530

  Maluf, P J ^a   Michelin, M A ^a   Etchebehere, R M ^a   Adad, S J ^a   Murta, E F C ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

CD3 lymphocyte; Cervical intraepithelial neoplasia grade III; Inflammatory infiltrate; Recurrence

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD45RO ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; B LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PROTEIN EXPRESSION; RECURRENT DISEASE; SCORING SYSTEM; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION;

ADULT; ANTIGENS, CD3; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NITRIC OXIDE SYNTHASE TYPE II; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 54449094899     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-008-0621-8     Document Type: Article

References (19)

1. AG Bais I Beckmann J Lindemans PC Ewing CJ Meijer PJ Snijders TJ Helmerhorst 2005 A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions J Clin Pathol 58 1096 1100
2. F BalkwilL A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 539 545
3. D Daniel C Chiu E Giraudo M Inoue LA Mizzen R Chun D Hanahan 2005 CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer Cancer Res 65 2018 2025
4. RI Demopoulos LE Horowitz EC Vamvakas 1991 Endocervical gland involvement by cervical intraepithelial neoplasia grade III: predictive value for residual and/or recurrent disease Cancer 68 1932 1936
5. JC Feoli-Fonseca LL Oligny P Brochu P Simard S Falconi WV Yotov 2001 Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR - direct sequencing approach J Med Virol 63 284 292
6. PC Fernandes Jr CB Garcia DC Micheli FQ Cunha EF Murta BM Tavares-Murta 2007 Circulating neutrophils may play a role in the host response in cervical cancer Int J Gynecol Cancer 17 1068 1074
7. JS Fine HD Byrnes PJ Zavodny RW Hipkin 2001 Evaluation of signal transduction pathways in chemoattractant-induced human monocyte chemotaxis Inflammation 25 61 67
8. ST Georgiannos A Renaut AW Goode M Sheaff 2003 The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators Surgery 134 827 834
9. LS Hammes RR Tekmal P Naud MI Edelweiss N Kirma PT Valente KJ Syrjanen JS Cunha-Filho 2007 Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression - clinicopathological correlation Gynecol Oncol 105 157 165
10. BN Lee M Follen DY Shen A Malpica K Adler-Storthz WT Shearer JM Reuben 2004 Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions Clin Diagn Lab Immunol 11 239 244
11. PJ Maluf SJ Adad EFC Murta 2004 Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses Tumori 90 473 477
12. MA Michelin EFC Murta 2008 Potential therapeutic, vaccine strategies and relevance of immune system in uterine cervical cancer Eur J Gynaecol Oncol 29 10 18
13. M Miyara S Sakaguchi 2007 Natural regulatory T cells: mechanisms of suppression Trends Mol Med 13 108 116
14. S Monnier-Benoit F Mauny D Riethmuller JS Guemini M Capilna S Felix E Seilles C Mougin JL Pretet 2006 Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant lesions of the uterine cervix Gynecol Oncol 102 22 31
15. MJE Mourits WJ Pieters H Hollema MP Burger 1992 Three-group metaphase as a morphologic criterion of progressive cervical intraepithelial neoplasia Am J Obstet Gynecol 167 591 595
16. EFC Murta AV Resende MA Souza SJ Adad R Salum 1999 Importance of surgical margins in conization for cervical intraepithelial neoplasia grade III Arch Gynecol Obstet 263 42 44
17. A Petter K Heim M Guger A Ciresa-Ko Nig N Christensen M Sarcletti U Wieland H Pfister R Zangerle R Hopfi 2000 Specific serum IgG, IgM and IgA antibodies to human papilomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women J Gen Virol 81 701 708
18. A Pinzon-Charry CS Ho R Laherty T Maxwell D Walker RA Gardiner L O'Connor C Pyke C Schmidt C Furnival JÁ Lopez 2005 Population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer Neoplasia 7 1112 1122
19. APS Terra EFC Murta PM Maluf OLSD Caballero M Brait SJ Adad 2007 Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III Tumori 93 572 579